Depletion of SMYD3 or mutation of its catalytic site causes phenotypes in PCa cells similar to disrupting its constitutive activation by K260 methylation or inhibiting the downstream MEK and ERK1/2 kinases. Here, SMYD3 is linked to posterior cortical atrophy.